Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 2
1 (100.0%)A Safety and Efficacy Study of Human Monoclonal Antibodies, BRII-196 and BRII-198 for the Treatment of Patients With COVID-19
Phase 2
Withdrawn
- Conditions
- COVID-19
- Interventions
- Drug: PlaceboDrug: BRII-196 and BRII-198
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Brii Biosciences, Inc.
- Registration Number
- NCT04770467
- Locations
- π¨π³
Investigative Site 1, Hong Kong, China
News
No news found